<p>Overall survival in relation to clinical-pathological characteristics of patients.</p
<p>Characteristics of the patients included in the survival study–qPCR Cohort.</p
<p>The univariate and multivariate analyses of overall survival in these patients.</p
<p>Characteristics of patients with accompanying NME according to pathologic results.</p
<p>Clinical parameters related to survival outcomes in all patients (Group A, N = 229).</p
<p>Progression-free survival in relation to clinical-pathological characteristics of patients.</p
<p>Overall survival according to clinicopathologic variables and AST/ALT ratio.</p
<p>Clinical characteristics of the patients according to pathological findings.</p
<p>Footnote: *, significantly associated with survival, N.A, not applicable.</p><p>Clinical and path...
Demographics and clinical characteristics of COVID-19 patients according to survival.</p
<p>Overall Survival (OS) according to stage (localized or metastatic disease).</p
<p>Overall Survival by type of therapy in patients with ECOG performance status of 0.</p
Clinical characteristics of the patients (overall and divided by the median Pre value).</p
<p><i>LPI</i> laboratory prognostic index, <i>ECOG</i> Eastern Cooperative Oncology Group, <i>PS</i>...
Comparison of observed, expected and relative survival times after diagnosis.</p
Characteristics of the study population according to hospital survival and neurological outcome.</p
<p>Characteristics of the patients included in the survival study–qPCR Cohort.</p
<p>The univariate and multivariate analyses of overall survival in these patients.</p
<p>Characteristics of patients with accompanying NME according to pathologic results.</p
<p>Clinical parameters related to survival outcomes in all patients (Group A, N = 229).</p
<p>Progression-free survival in relation to clinical-pathological characteristics of patients.</p
<p>Overall survival according to clinicopathologic variables and AST/ALT ratio.</p
<p>Clinical characteristics of the patients according to pathological findings.</p
<p>Footnote: *, significantly associated with survival, N.A, not applicable.</p><p>Clinical and path...
Demographics and clinical characteristics of COVID-19 patients according to survival.</p
<p>Overall Survival (OS) according to stage (localized or metastatic disease).</p
<p>Overall Survival by type of therapy in patients with ECOG performance status of 0.</p
Clinical characteristics of the patients (overall and divided by the median Pre value).</p
<p><i>LPI</i> laboratory prognostic index, <i>ECOG</i> Eastern Cooperative Oncology Group, <i>PS</i>...
Comparison of observed, expected and relative survival times after diagnosis.</p
Characteristics of the study population according to hospital survival and neurological outcome.</p
<p>Characteristics of the patients included in the survival study–qPCR Cohort.</p
<p>The univariate and multivariate analyses of overall survival in these patients.</p
<p>Characteristics of patients with accompanying NME according to pathologic results.</p